CHARLES RIVER LABORATORIES INTERNATIONAL, INC.·4

Aug 5, 4:04 PM ET

FOSTER JAMES C 4

4 · CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · Filed Aug 5, 2024

Insider Transaction Report

Form 4
Period: 2024-08-01
FOSTER JAMES C
DirectorChairman, President and CEO
Transactions
  • Sale

    Common Stock

    2024-08-01$250.00/sh25,000$6,250,000188,251 total
Holdings
  • Common Stock

    (indirect: 2023 GRAT)
    9,793
  • Common Stock

    (indirect: By Trust)
    2,250
  • Common Stock

    (indirect: 2022 GRAT)
    7,580
  • Common Stock

    (indirect: 2024 GRAT)
    20,000
  • Common Stock

    (indirect: By Trust)
    750
  • Common Stock

    (indirect: By Spouse)
    10,000
  • Common Stock

    (indirect: By Trust)
    230
Footnotes (4)
  • [F1]This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 26, 2024.
  • [F2]On 6/5/2024, 10,207 shares were transferred from the 2023 GRAT account to Direct holdings.
  • [F3]On 6/6/2024, 20,000 shares were transferred from Direct holdings to 2024 GRAT account.
  • [F4]Reflects a reduction by 110 shares that were inadvertently reported as being held by the Reporting Person.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT